Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Acta Neuropathologica|April 1, 2025
Impaired remyelination in late-onset multiple sclerosisLidia Stork, Schirin Stephan, Adriane Kutllovci, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 11, 2026
Brain Immune Cell Composition in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy After Natalizumab: An Immunohistochemical Cohort StudyBenita-Sophie Raabe, Lidia Stork, Adriane Kutllovci, et al.
Journal of Neurology|November 14, 2022
Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological-serological correlative studyAnne-Sophie Dietmann, Niels Kruse, Lidia Stork, et al.
Brain Pathology (Zurich, Switzerland)|May 6, 2021
CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort studyDarius Häusler, Katja Akgün, Lidia Stork, et al.
Neurology|June 24, 2018
Drug reaction with eosinophilia and systemic symptoms after daclizumab therapySebastian Rauer, Lidia Stork, Horst Urbach, et al.
Neuro-Oncology Practice|August 15, 2025
Histopathologically confirmed radiation necrosis: Risk factors and clinical outcomes in patients with primary brain tumorsMohammad Hazaymeh, Vesna Malinova, Lidia Stork, et al.
Acta Neuropathologica|January 18, 2020
Antibody signatures in patients with histopathologically defined multiple sclerosis patternsLidia Stork, David Ellenberger, Klemens Ruprecht, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 20, 2016
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosisImke Metz, Tim Beißbarth, David Ellenberger, et al.
Pageof 2